Concepedia

3507 ORAL Sorafenib improves survival in a large multi-center, randomized, placebo-controlled phase III trial in patients with hepatocellular carcinoma

Josep M. Llovet, Vincenzo Mazzaferro, Serena Ricci, P Hilgard, Jean‐Luc Raoul, Stefan Zeuzem, Minghua Shan, M. Moscovici, D. Voliotis

European Journal of Cancer Supplements · 2007 · 31 citations · 0 references

Concepts

MedicineOncologyPharmacologyCancer PharmacologyHepatobiliary CancerHepatocellular CarcinomaHepatocellular Carcinoma PharmacotherapyLiver CancerHepatocellular Carcinoma TreatmentLiver Metastases TreatmentLiver Tumor TherapyPlacebo-controlled Efficacy AssessmentSorafenib Therapy